Cross Country Healthcare Inc (CCRN)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	72,631	102,384	124,365	155,914	188,461	227,243	215,883	174,537	132,002	59,041	34,274	8,575	-12,962	-18,718	-20,512	-58,035	-57,713	-76,260	-73,573	-20,360
Total stockholders’ equity	US$ in thousands	473,393	469,661	470,348	451,930	457,219	422,709	410,811	356,073	297,528	216,799	191,597	173,140	154,375	148,410	148,647	160,757	162,632	162,893	163,961	215,316
ROE		15.34%	21.80%	26.44%	34.50%	41.22%	53.76%	52.55%	49.02%	44.37%	27.23%	17.89%	4.95%	-8.40%	-12.61%	-13.80%	-36.10%	-35.49%	-46.82%	-44.87%	-9.46%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $72,631K ÷ $473,393K
= 15.34%

Cross Country Healthcares, Inc.'s return on equity (ROE) has shown a decreasing trend over the past eight quarters. The ROE decreased from 49.02% in Q1 2022 to 15.34% in Q4 2023. This declining trend indicates that the company's ability to generate profits from its shareholders' equity has weakened over time.

A high ROE is generally considered favorable as it indicates efficient utilization of equity to generate profits. However, the decreasing trend in Cross Country Healthcares, Inc.'s ROE may raise concerns about the company's profitability and efficiency in utilizing its shareholders' equity.

It is essential for the company to identify the factors contributing to this decline in ROE and take necessary measures to address them. This may involve improving operational efficiency, controlling costs, enhancing revenue generation, or restructuring the capital structure to optimize shareholder returns.

Investors and stakeholders should closely monitor Cross Country Healthcares, Inc.'s financial performance and management's actions to improve ROE in order to assess the company's long-term sustainability and value creation potential.